The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

COMBINED PERPHENAZINE-AMITRIPTYLINE AS ADJUVANT THERAPY IN PSYCHIATRIC AFTERCARE

Published Online:https://doi.org/10.1176/ajp.121.5.498

An amitriptyline-perphenazine combination was used to treat the mixed anxiety, tension, and depression which may occur in patients being maintained on phenothiazines. Of 33 such patients seen regularly in a community aftercare clinic, 29 (88%) showed considerable or total remission of symptoms. Dizziness, nausea, and vomiting required discontinuing amitriptyline-perphenazine therapy in 3 patients. One patient complained of dry mouth. This drug combination may be of great help in the maintenance therapy of psychotic outpatients. Further study would seem to be warranted.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.